Doctor profile · Federal record
Dr. DONNA SCHARCH, FNP-C
Nurse Practitioner · Family Nurse Practitioner · CENTREVILLE, MD
- NPI 1043875719
- Accepts Medicare
- MIPS 76.8 / 100 · 2023
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2977 FOUR H PARK RD STE 102
CENTREVILLE, MD 216172237
(410) 758-4030
fax (410) 758-4733 - Mailing address
-
PO BOX 749495
ATLANTA, GA 303749495
Credentials & registration
- NPI registered
- May 2019 — 7 yrs on file
- Profile last updated
- May 14, 2024
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Maryland #R118232
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043875719. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,136
Distinct HCPCS
6
Medicare allowed
$256,367
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,205 | 265 | $110 | |
80307 |
Testing for presence of drug, by chemistry analyzers | 355 | 197 | $61 | |
G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 334 | 186 | $194 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 204 | 91 | $156 | |
G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 23 | 20 | $153 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 15 | 15 | $145 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 356. This provider delivers 6.0× the peer median.Open Payments
Industry payments received
All-time total
$1,045
Transactions
28
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $159.37 | |
| Gilead Sciences, Inc. | 3 | $120.29 | |
| SOBI, INC | 1 | $112.04 | |
| AstraZeneca Pharmaceuticals LP | 3 | $72.24 | |
| Novartis Pharmaceuticals Corporation | 3 | $61.18 | |
| Merck Sharp & Dohme LLC | 3 | $54.14 | |
| Eisai Inc. | 1 | $53.75 | |
| Daiichi Sankyo Inc. | 3 | $47.65 | |
| Astellas Pharma US Inc | 2 | $37.92 | |
| Immunocore Limited | 1 | $34.55 | |
| BeiGene USA, Inc. | 1 | $34.00 | |
| PharmaEssentia USA Corporation | 1 | $32.54 | |
| Amneal Pharmaceuticals LLC | 1 | $28.66 | |
| Tempus AI, Inc | 1 | $26.48 | |
| Blueprint Medicines Corporation | 1 | $26.16 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,162
Patients
674
Total drug cost
$114,795
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 748 | 129 | $18,616 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 508 | 91 | $19,234 |
| Gabapentin | Generic | 461 | 99 | $5,916 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 201 | 54 | $5,528 |
| Pregabalin | Generic | 199 | 50 | $7,863 |
| Tizanidine Hcl | Generic | 188 | 44 | $2,720 |
| Tramadol Hcl | Generic | 176 | 36 | $2,561 |
| Cyclobenzaprine Hcl | Generic | 174 | 42 | $2,483 |
| Morphine Sulfate Er (Morphine Sulfate) | Brand | 126 | 18 | $3,073 |
| Diclofenac Sodium | Generic | 103 | 31 | $3,444 |